佛慈制药：2025年第三季度归属于上市公司股东的净利润同比增长167.92%

Group 1 - The core point of the article is that 佛慈制药 reported a decline in revenue for the third quarter of 2025, while net profit saw a significant increase compared to the previous year [2] Group 2 - In the third quarter of 2025, the company achieved operating revenue of 194,689,733.90 yuan, representing a year-on-year decrease of 7.14% [2] - The net profit attributable to shareholders of the listed company was 7,977,760.05 yuan, showing a year-on-year growth of 167.92% [2]